CompletedNot Applicable

A Study on Sumac Mouth Rinse for Treating Recurrent Aphthous Stomatitis

Egypt38 participantsStarted 2023-12-20

Plain-language summary

This randomized controlled clinical study aims to evaluate the effectiveness of a Sumac mouth rinse in the management of recurrent aphthous stomatitis (RAS). In addition to assessing clinical improvement in ulcer healing and pain reduction, biochemical analysis will be performed by measuring serum TNF-α levels to evaluate the anti-inflammatory effect of Sumac.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 18 years or older * Systemically healthy * Patients with recurrent aphthous stomatitis minor type * Duration of ulcer does not exceed 2 days * Oral pain score of 4 or higher on the Visual Analog Scale (VAS) Exclusion Criteria: * Patients with poor oral hygiene * Smokers and alcohol users * Pregnant or lactating females * Patients with a history of any topical or systemic medication or steroid therapy within 1 month prior to the study * Vulnerable populations such as prisoners or individuals with mental or physical disabilities

What they're measuring

Pain (VAS)

Timeframe: At the baseline / Day 2 / Day 6

Ulcer size

Timeframe: At the baseline / Day 2 / Day 6

Trial details

NCT IDNCT07229469

SponsorAin Shams University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-25

View on ClinicalTrials.gov More Recurrent Aphthous Stomatitis trials